Member Info for RENE_to_40p

Charlie Elphicke / Michael Hunt
Michael Hunt / Charlie Elphicke
... anyone ever seen them in the same room together?

Because it went up for no reason

So the recent rise was off the back of the article suggesting it could be a takeover target but there's no substance to that whatsoever so it's going back down again.

Is that right?

Either that or the MM's laughing and encouraging the rise only to drop the arse out of it a few days later. Usually what happens with RENE!

i see a whole page of buys ... and then an RNS.

No, AIM isn't bent at all. Honest.

If they get to market in RP or CTX then the SP will be many multiples higher but there are hundreds, maybe even thousands of biotech companies out there who all think they've got the next great new treatment. The fact is that only a tiny percentage of them make it successfully to market and realistically, even if they are ultimately successful, it's still years off for RENE. That's why the SP will remain depressed in the meantime. If they make it, many multiples, if they don't, you lose all your investment money.
Also, despite the Fosun deal, the company clearly will need to raise more cash before too long. That could be another partnering deal or it could be a share issue.
These are the facts and, along with Woodford's negative influence, would-be investors are most likely waiting on the sidelines for some concrete milestones. It's still way too speculative a share for most serious investors. It's for gamblers, basically.

So the MM's can sucker in a few people to buy before dropping the arse out of it tomorrow

I'll refrain from posting in future rather then bring a downer on here. It's just I've seen it all before with RENE more times than I care to remember.

I hope I'm wrong for all long term holders sakes.

So either silence from me, or I'll be back ramping once I've bought back in sub £1 :)

Good luck folks.

Desperation RNS trying to boost SP before huge cash call.

Today finish at 120p

Thanks PC01, much appreciated.

Nope, sorry, still don't understand.

Can anyone explain what that RNS means in plain English, including how/why whatever has happened has only happened to half of Woodford's holding, not all of it?

Yes, I think you could be right. It looks like Link Fund Solutions have taken Woodford's holdings in Arix, Eve Sleep and a number of other companies over the last few days too.

So who are they and what's going on?

It might be if we actually understood what the RNS means, for definite.

Why is everything smoke and mirrors on AIM FFS?!

I take your point PhilBanks.

'No trading in the stock - voting control interest over stock transferred to new manager'

What does that actually mean?

Looks like Woodford's half out. That's pretty significant, he's been able to offload a LOT of shares.

Might be worth dipping the toe back in here now.

www.sharesmagazine.co.uk/video/reneuron-group-rene-michael-hunt-cfo

Listen around 23:30

Next things to look forward to: cash call and 12 months of silence

It's starting to look like a total basket case company. I don't like Olav's attitude at all or his turn of phrase. "Just toss it [CTX]" and now "Lost a lot of letters" both deeply disrespectful to patients in both trials. I don't want to be invested in a company with him involved.

I've always liked Michael Hunt. He's much more measured, respectful and professional. I wish him all the best.

Michael Hunt recently acknowledged the need to raise more funds. They should've done that on the back of recent rises. It would've been briefly unpopular and hit us a bit but worth it to have enough cash to get through. Big opportunity missed.

Also Woodford elephant in the room which none of us really knows how it will play out but it's like the company's wearing lead boots all the time he's around.

And for those reasons, I'm out.

Nice one Olav. Another marketing triumph. You idiot.

Michael Hunt mentioned a cash call being needed soon in that recent video. Something we all conveniently disregarded on here. I was hoping for results and a surge that they could tap in to for a few quid but that looks to have gone out the window.

Super disappointing day.

Every single patient has shown improvement, many of them spectacular improvement. That's unprecedented in RP. Market cap is way, WAY under.